Axcella Health Inc. – NASDAQ:AXLA

Financial Health
0
1
2
3
4
5
6
7
8
9

Axcella Health stock price monthly change

+1042.43%
month

Axcella Health stock price quarterly change

+1042.43%
quarter

Axcella Health stock price yearly change

+1004.68%
year

Axcella Health key metrics

Market Cap
N/A
Enterprise value
7.84M
P/E
-0.28
EV/Sales
N/A
EV/EBITDA
-0.06
Price/Sales
N/A
Price/Book
5.48
PEG ratio
-0.02
EPS
-0.89
Revenue
N/A
EBITDA
-35.43M
Income
-50.02M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Axcella Health stock price history

Axcella Health stock forecast

Axcella Health financial statements

Axcella Health Inc. (NASDAQ:AXLA): Profit margin
Sep 2022 0 -18.58M
Dec 2022 0 -24.25M
Mar 2023 0 -3.76M
Jun 2023 0 -3.41M
Axcella Health Inc. (NASDAQ:AXLA): Analyst Estimates
2025 0 -15.94M
  • Analysts Price target

  • Financials & Ratios estimates

Axcella Health Inc. (NASDAQ:AXLA): Debt to assets
Sep 2022 30788000 38.34M 124.53%
Dec 2022 18927000 14.76M 78%
Mar 2023 12765000 12.03M 94.3%
Jun 2023 9282000 11.54M 124.33%
Axcella Health Inc. (NASDAQ:AXLA): Cash Flow
Sep 2022 -18.52M 10.17M -301K
Dec 2022 -15.53M -19K 7.27M
Mar 2023 -5.10M 525K -27K
Jun 2023 -3.65M 0 13.32B

Axcella Health alternative data

Axcella Health Inc. (NASDAQ:AXLA): Employee count
Aug 2023 11
Sep 2023 11
Oct 2023 11
Nov 2023 11
Dec 2023 11
Jan 2024 11
Feb 2024 11
Mar 2024 11
Apr 2024 11
May 2024 11
Jun 2024 11
Jul 2024 11

Axcella Health other data

32.89% -60.45%
of AXLA is owned by hedge funds
17.87M -31.26M
shares is hold by hedge funds

Axcella Health Inc. (NASDAQ:AXLA): Insider trades (number of shares)
Period Buy Sel
Jun 2022 0 590
Sep 2022 0 547
Oct 2022 14042296 16000
Feb 2023 0 5221
Mar 2023 0 679
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KOZIEL MARGARET officer: Chief Medical Officer
Common Stock 679 $0.58 $394
Sale
FEHLNER PAUL officer: SVP & Chief Legal Offi..
Common Stock 5,221 $0.66 $3,446
Sale
HINSHAW WILLIAM director, officer.. Common Stock 16,000 $1.56 $25,024
Purchase
SOCIETE DES PRODUITS NESTLE S.A. 10 percent owner
Common Stock 3,658,536 $1.64 $5,999,999
Purchase
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent owner
Common Stock 2,743,902 $1.64 $4,499,999
Purchase
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent owner
Common Stock 3,048,780 $1.64 $4,999,999
Purchase
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent owner
Common Stock 919,111 $1.64 $1,507,342
Purchase
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent owner
Common Stock 914,634 $1.64 $1,500,000
Purchase
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent owner
Common Stock 2,757,333 $1.64 $4,522,026
Sale
KOZIEL MARGARET officer: Chief Medical Officer
Common Stock 547 $2.52 $1,378
Patent
Grant
Filling date: 19 Jun 2019 Issue date: 12 Apr 2022
Grant
Filling date: 19 Dec 2017 Issue date: 28 Sep 2021
Application
Filling date: 8 Jun 2021 Issue date: 23 Sep 2021
Application
Filling date: 2 Mar 2021 Issue date: 23 Sep 2021
Application
Filling date: 19 Jun 2019 Issue date: 9 Sep 2021
Application
Filling date: 19 Jun 2019 Issue date: 9 Sep 2021
Application
Filling date: 19 Jun 2019 Issue date: 26 Aug 2021
Grant
Filling date: 19 Jun 2019 Issue date: 13 Jul 2021
Application
Filling date: 9 Oct 2020 Issue date: 6 May 2021
Grant
Filling date: 7 Feb 2020 Issue date: 13 Apr 2021
Sunday, 8 October 2023
InvestorPlace
Wednesday, 20 September 2023
InvestorPlace
Friday, 15 September 2023
Zacks Investment Research
InvestorPlace
Thursday, 31 August 2023
InvestorPlace
Wednesday, 30 August 2023
Zacks Investment Research
Tuesday, 29 August 2023
InvestorPlace
Proactive Investors
Tuesday, 22 August 2023
InvestorPlace
Thursday, 16 February 2023
InvestorPlace
Thursday, 26 January 2023
PennyStocks
Wednesday, 25 January 2023
PennyStocks
Tuesday, 24 January 2023
InvestorPlace
Tuesday, 20 December 2022
PennyStocks
Friday, 11 November 2022
Zacks Investment Research
Thursday, 3 November 2022
Business Wire
Tuesday, 1 November 2022
Seeking Alpha
Thursday, 29 September 2022
Market Watch
Tuesday, 9 August 2022
Zacks Investment Research
Friday, 27 May 2022
Zacks Investment Research
Wednesday, 30 March 2022
Seeking Alpha
Wednesday, 23 March 2022
Business Wire
Thursday, 17 March 2022
Benzinga
Monday, 14 February 2022
Pulse2
Thursday, 30 December 2021
Zacks Investment Research
Wednesday, 8 December 2021
Zacks Investment Research
Monday, 15 November 2021
Zacks Investment Research
Wednesday, 10 November 2021
Zacks Investment Research
Tuesday, 26 October 2021
Benzinga
Tuesday, 28 September 2021
Benzinga
  • When is Axcella Health's next earnings date?

    Unfortunately, Axcella Health's (AXLA) next earnings date is currently unknown.

  • Does Axcella Health pay dividends?

    No, Axcella Health does not pay dividends.

  • What is Axcella Health's stock symbol?

    Axcella Health Inc. is traded on the NASDAQ under the ticker symbol "AXLA".

  • What is Axcella Health's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Axcella Health?

    Shares of Axcella Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Axcella Health's key executives?

    Axcella Health's management team includes the following people:

    • Mr. William R. Hinshaw Jr. Pres, Chief Executive Officer & Director(age: 56, pay: $812,050)
    • Mr. Laurent Chardonnet Consultant(age: 60, pay: $576,060)
  • How many employees does Axcella Health have?

    As Jul 2024, Axcella Health employs 11 workers.

  • When Axcella Health went public?

    Axcella Health Inc. is publicly traded company for more then 6 years since IPO on 9 May 2019.

  • What is Axcella Health's official website?

    The official website for Axcella Health is axcellahealth.com.

  • Where are Axcella Health's headquarters?

    Axcella Health is headquartered at 840 Memorial Drive, Cambridge, MA.

  • How can i contact Axcella Health?

    Axcella Health's mailing address is 840 Memorial Drive, Cambridge, MA and company can be reached via phone at 857 320 2200.

Axcella Health company profile:

Axcella Health Inc.

axcellahealth.com
Exchange:

NASDAQ

Full time employees:

11

Industry:

Biotechnology

Sector:

Healthcare

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

840 Memorial Drive
Cambridge, MA 02139

CIK: 0001633070
ISIN: US05454B2043
CUSIP: 05454B105